Cargando…
A novel germline HAVCR2 (TIM-3) compound heterozygous mutation is related to hemophagocytic lymphohistiocytic syndrome in EBV-positive peripheral T-cell lymphoma (NOS) with down-regulated TIM-3 signaling
Recently, it have been reported that Hepatitis A Virus-Cellular Receptor 2(HAVCR2,encoding T-cell immunoglobulin and Mucin-Containing Protein 3[TIM3]) mutations are associated with severe hemophagocytic syndrome(HLH) in subcutaneous panniculitis-like T-cell lymphoma(SPTCL),and there are also frequen...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539911/ https://www.ncbi.nlm.nih.gov/pubmed/36212426 http://dx.doi.org/10.3389/fonc.2022.870676 |
_version_ | 1784803594645536768 |
---|---|
author | Zhang, Yang Wang, Zhihua Hu, Guoyu Li, Jieping Chen, Yongheng Jiang, Yi Zhong, Haiying Liu, Xianling Hu, Chunhong Peng, Honglin Xu, Yunxiao Cheng, Zhao Zhang, Guangsen |
author_facet | Zhang, Yang Wang, Zhihua Hu, Guoyu Li, Jieping Chen, Yongheng Jiang, Yi Zhong, Haiying Liu, Xianling Hu, Chunhong Peng, Honglin Xu, Yunxiao Cheng, Zhao Zhang, Guangsen |
author_sort | Zhang, Yang |
collection | PubMed |
description | Recently, it have been reported that Hepatitis A Virus-Cellular Receptor 2(HAVCR2,encoding T-cell immunoglobulin and Mucin-Containing Protein 3[TIM3]) mutations are associated with severe hemophagocytic syndrome(HLH) in subcutaneous panniculitis-like T-cell lymphoma(SPTCL),and there are also frequent mutations in sporadic SPTCL, suggesting the individuals harboring HAVCR2(TIM-3) germline mutations are highly susceptible to familial or sporadic SPTCL. Here, we identify a novel germline compound heterozygous mutation of TIM-3 gene,c.245A>G (p.Tyr82Cys) and c.265C>T(p.Arg89Cys) variations in a single familial case with EBV-positive peripheral T-cell lymphoma(NOS),accompanied HLH;we also detected Tyr82Cys germline mutation in TIM-3 gene in one sporadic patient with cutaneous T cell lymphoma. We screened the distributive frequencies for TIM-3 mutations in healthy controls(n=87), B-(n=79) or T-cell lymphoma(n=25) not SPTCL, and the results showed that the mutation was found in two out of 25 patients with T-cell lymphoma but was not detected in 79 patients with B-cell lymphoma nor in a group of 87 controls. The mRNA expression of TIM-3 on primary cells and transfected HEK293 cells reduced significantly, indicating Tyr82Cys and Arg89Cys mutations is a loss-of function mutations on TIM-3,resulting in a weakened TIM-3 signaling. Our results suggest Tyr82Cys TIM-3 germline mutations are not only limited in SPTCL, and also occurred in other types of T-cell lymphoma, especially complicated HLH. TIM-3 mutations may be an predisposing factor for T-cell lymphoma and molecular marker for auxiliary diagnosis in T cell lymphoma,especially complicated with HLH. |
format | Online Article Text |
id | pubmed-9539911 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95399112022-10-08 A novel germline HAVCR2 (TIM-3) compound heterozygous mutation is related to hemophagocytic lymphohistiocytic syndrome in EBV-positive peripheral T-cell lymphoma (NOS) with down-regulated TIM-3 signaling Zhang, Yang Wang, Zhihua Hu, Guoyu Li, Jieping Chen, Yongheng Jiang, Yi Zhong, Haiying Liu, Xianling Hu, Chunhong Peng, Honglin Xu, Yunxiao Cheng, Zhao Zhang, Guangsen Front Oncol Oncology Recently, it have been reported that Hepatitis A Virus-Cellular Receptor 2(HAVCR2,encoding T-cell immunoglobulin and Mucin-Containing Protein 3[TIM3]) mutations are associated with severe hemophagocytic syndrome(HLH) in subcutaneous panniculitis-like T-cell lymphoma(SPTCL),and there are also frequent mutations in sporadic SPTCL, suggesting the individuals harboring HAVCR2(TIM-3) germline mutations are highly susceptible to familial or sporadic SPTCL. Here, we identify a novel germline compound heterozygous mutation of TIM-3 gene,c.245A>G (p.Tyr82Cys) and c.265C>T(p.Arg89Cys) variations in a single familial case with EBV-positive peripheral T-cell lymphoma(NOS),accompanied HLH;we also detected Tyr82Cys germline mutation in TIM-3 gene in one sporadic patient with cutaneous T cell lymphoma. We screened the distributive frequencies for TIM-3 mutations in healthy controls(n=87), B-(n=79) or T-cell lymphoma(n=25) not SPTCL, and the results showed that the mutation was found in two out of 25 patients with T-cell lymphoma but was not detected in 79 patients with B-cell lymphoma nor in a group of 87 controls. The mRNA expression of TIM-3 on primary cells and transfected HEK293 cells reduced significantly, indicating Tyr82Cys and Arg89Cys mutations is a loss-of function mutations on TIM-3,resulting in a weakened TIM-3 signaling. Our results suggest Tyr82Cys TIM-3 germline mutations are not only limited in SPTCL, and also occurred in other types of T-cell lymphoma, especially complicated HLH. TIM-3 mutations may be an predisposing factor for T-cell lymphoma and molecular marker for auxiliary diagnosis in T cell lymphoma,especially complicated with HLH. Frontiers Media S.A. 2022-09-23 /pmc/articles/PMC9539911/ /pubmed/36212426 http://dx.doi.org/10.3389/fonc.2022.870676 Text en Copyright © 2022 Zhang, Wang, Hu, Li, Chen, Jiang, Zhong, Liu, Hu, Peng, Xu, Cheng and Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Zhang, Yang Wang, Zhihua Hu, Guoyu Li, Jieping Chen, Yongheng Jiang, Yi Zhong, Haiying Liu, Xianling Hu, Chunhong Peng, Honglin Xu, Yunxiao Cheng, Zhao Zhang, Guangsen A novel germline HAVCR2 (TIM-3) compound heterozygous mutation is related to hemophagocytic lymphohistiocytic syndrome in EBV-positive peripheral T-cell lymphoma (NOS) with down-regulated TIM-3 signaling |
title | A novel germline HAVCR2 (TIM-3) compound heterozygous mutation is related to hemophagocytic lymphohistiocytic syndrome in EBV-positive peripheral T-cell lymphoma (NOS) with down-regulated TIM-3 signaling |
title_full | A novel germline HAVCR2 (TIM-3) compound heterozygous mutation is related to hemophagocytic lymphohistiocytic syndrome in EBV-positive peripheral T-cell lymphoma (NOS) with down-regulated TIM-3 signaling |
title_fullStr | A novel germline HAVCR2 (TIM-3) compound heterozygous mutation is related to hemophagocytic lymphohistiocytic syndrome in EBV-positive peripheral T-cell lymphoma (NOS) with down-regulated TIM-3 signaling |
title_full_unstemmed | A novel germline HAVCR2 (TIM-3) compound heterozygous mutation is related to hemophagocytic lymphohistiocytic syndrome in EBV-positive peripheral T-cell lymphoma (NOS) with down-regulated TIM-3 signaling |
title_short | A novel germline HAVCR2 (TIM-3) compound heterozygous mutation is related to hemophagocytic lymphohistiocytic syndrome in EBV-positive peripheral T-cell lymphoma (NOS) with down-regulated TIM-3 signaling |
title_sort | novel germline havcr2 (tim-3) compound heterozygous mutation is related to hemophagocytic lymphohistiocytic syndrome in ebv-positive peripheral t-cell lymphoma (nos) with down-regulated tim-3 signaling |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539911/ https://www.ncbi.nlm.nih.gov/pubmed/36212426 http://dx.doi.org/10.3389/fonc.2022.870676 |
work_keys_str_mv | AT zhangyang anovelgermlinehavcr2tim3compoundheterozygousmutationisrelatedtohemophagocyticlymphohistiocyticsyndromeinebvpositiveperipheraltcelllymphomanoswithdownregulatedtim3signaling AT wangzhihua anovelgermlinehavcr2tim3compoundheterozygousmutationisrelatedtohemophagocyticlymphohistiocyticsyndromeinebvpositiveperipheraltcelllymphomanoswithdownregulatedtim3signaling AT huguoyu anovelgermlinehavcr2tim3compoundheterozygousmutationisrelatedtohemophagocyticlymphohistiocyticsyndromeinebvpositiveperipheraltcelllymphomanoswithdownregulatedtim3signaling AT lijieping anovelgermlinehavcr2tim3compoundheterozygousmutationisrelatedtohemophagocyticlymphohistiocyticsyndromeinebvpositiveperipheraltcelllymphomanoswithdownregulatedtim3signaling AT chenyongheng anovelgermlinehavcr2tim3compoundheterozygousmutationisrelatedtohemophagocyticlymphohistiocyticsyndromeinebvpositiveperipheraltcelllymphomanoswithdownregulatedtim3signaling AT jiangyi anovelgermlinehavcr2tim3compoundheterozygousmutationisrelatedtohemophagocyticlymphohistiocyticsyndromeinebvpositiveperipheraltcelllymphomanoswithdownregulatedtim3signaling AT zhonghaiying anovelgermlinehavcr2tim3compoundheterozygousmutationisrelatedtohemophagocyticlymphohistiocyticsyndromeinebvpositiveperipheraltcelllymphomanoswithdownregulatedtim3signaling AT liuxianling anovelgermlinehavcr2tim3compoundheterozygousmutationisrelatedtohemophagocyticlymphohistiocyticsyndromeinebvpositiveperipheraltcelllymphomanoswithdownregulatedtim3signaling AT huchunhong anovelgermlinehavcr2tim3compoundheterozygousmutationisrelatedtohemophagocyticlymphohistiocyticsyndromeinebvpositiveperipheraltcelllymphomanoswithdownregulatedtim3signaling AT penghonglin anovelgermlinehavcr2tim3compoundheterozygousmutationisrelatedtohemophagocyticlymphohistiocyticsyndromeinebvpositiveperipheraltcelllymphomanoswithdownregulatedtim3signaling AT xuyunxiao anovelgermlinehavcr2tim3compoundheterozygousmutationisrelatedtohemophagocyticlymphohistiocyticsyndromeinebvpositiveperipheraltcelllymphomanoswithdownregulatedtim3signaling AT chengzhao anovelgermlinehavcr2tim3compoundheterozygousmutationisrelatedtohemophagocyticlymphohistiocyticsyndromeinebvpositiveperipheraltcelllymphomanoswithdownregulatedtim3signaling AT zhangguangsen anovelgermlinehavcr2tim3compoundheterozygousmutationisrelatedtohemophagocyticlymphohistiocyticsyndromeinebvpositiveperipheraltcelllymphomanoswithdownregulatedtim3signaling AT zhangyang novelgermlinehavcr2tim3compoundheterozygousmutationisrelatedtohemophagocyticlymphohistiocyticsyndromeinebvpositiveperipheraltcelllymphomanoswithdownregulatedtim3signaling AT wangzhihua novelgermlinehavcr2tim3compoundheterozygousmutationisrelatedtohemophagocyticlymphohistiocyticsyndromeinebvpositiveperipheraltcelllymphomanoswithdownregulatedtim3signaling AT huguoyu novelgermlinehavcr2tim3compoundheterozygousmutationisrelatedtohemophagocyticlymphohistiocyticsyndromeinebvpositiveperipheraltcelllymphomanoswithdownregulatedtim3signaling AT lijieping novelgermlinehavcr2tim3compoundheterozygousmutationisrelatedtohemophagocyticlymphohistiocyticsyndromeinebvpositiveperipheraltcelllymphomanoswithdownregulatedtim3signaling AT chenyongheng novelgermlinehavcr2tim3compoundheterozygousmutationisrelatedtohemophagocyticlymphohistiocyticsyndromeinebvpositiveperipheraltcelllymphomanoswithdownregulatedtim3signaling AT jiangyi novelgermlinehavcr2tim3compoundheterozygousmutationisrelatedtohemophagocyticlymphohistiocyticsyndromeinebvpositiveperipheraltcelllymphomanoswithdownregulatedtim3signaling AT zhonghaiying novelgermlinehavcr2tim3compoundheterozygousmutationisrelatedtohemophagocyticlymphohistiocyticsyndromeinebvpositiveperipheraltcelllymphomanoswithdownregulatedtim3signaling AT liuxianling novelgermlinehavcr2tim3compoundheterozygousmutationisrelatedtohemophagocyticlymphohistiocyticsyndromeinebvpositiveperipheraltcelllymphomanoswithdownregulatedtim3signaling AT huchunhong novelgermlinehavcr2tim3compoundheterozygousmutationisrelatedtohemophagocyticlymphohistiocyticsyndromeinebvpositiveperipheraltcelllymphomanoswithdownregulatedtim3signaling AT penghonglin novelgermlinehavcr2tim3compoundheterozygousmutationisrelatedtohemophagocyticlymphohistiocyticsyndromeinebvpositiveperipheraltcelllymphomanoswithdownregulatedtim3signaling AT xuyunxiao novelgermlinehavcr2tim3compoundheterozygousmutationisrelatedtohemophagocyticlymphohistiocyticsyndromeinebvpositiveperipheraltcelllymphomanoswithdownregulatedtim3signaling AT chengzhao novelgermlinehavcr2tim3compoundheterozygousmutationisrelatedtohemophagocyticlymphohistiocyticsyndromeinebvpositiveperipheraltcelllymphomanoswithdownregulatedtim3signaling AT zhangguangsen novelgermlinehavcr2tim3compoundheterozygousmutationisrelatedtohemophagocyticlymphohistiocyticsyndromeinebvpositiveperipheraltcelllymphomanoswithdownregulatedtim3signaling |